Literature DB >> 15971195

Enrichment of low-abundant serum proteins by albumin/immunoglobulin G immunoaffinity depletion under partly denaturing conditions.

Hong-Lei Huang1, Taras Stasyk, Sandra Morandell, Maurice Mogg, Martin Schreiber, Isabel Feuerstein, Christian W Huck, Guenther Stecher, Guenther K Bonn, Lukas A Huber.   

Abstract

We present a simple protocol for affinity depletion to remove the two most abundant serum proteins, albumin and immunoglobulin G (IgG). Under native conditions, albumin/IgG were efficiently removed and several proteins were enriched as shown by two-dimensional electrophoresis (2-DE). Besides that, partly denaturing conditions were established by adding 5 or 20% acetonitrile (ACN) in order to disrupt the binding of low-molecular-weight (LMW) proteins to the carrier proteins albumin/IgG. 2-DE results showed that the total number of detected LMW proteins increased under denaturing conditions when compared to native conditions. Interestingly, the presence of 5% ACN in serum revealed better enrichment of LMW proteins when compared to 20% ACN condition. Seven randomly distributed spots in albumin/IgG depleted serum samples under 5% ACN condition were picked from the 2-DE gels and identified by mass spectrometry (MS). The intensity of five LMW protein spots increased under denaturing conditions when compared to native conditions. Three of the seven identified spots (serum amyloid P, vitamin D-binding protein, and transthyretin) belong to a group of relatively low-abundant proteins, which make up only 1% of all serum proteins. The method presented here improves the resolution of the serum proteome by increasing the number of visualized spots on 2-D gels and allowing the detection and MS identification of LMW proteins and proteins of lower abundance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15971195     DOI: 10.1002/elps.200500167

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  15 in total

1.  Biomarker discovery and clinical proteomics.

Authors:  Jerzy Silberring; Pawel Ciborowski
Journal:  Trends Analyt Chem       Date:  2010-02-01       Impact factor: 12.296

2.  Evaluation of multiprotein immunoaffinity subtraction for plasma proteomics and candidate biomarker discovery using mass spectrometry.

Authors:  Tao Liu; Wei-Jun Qian; Heather M Mottaz; Marina A Gritsenko; Angela D Norbeck; Ronald J Moore; Samuel O Purvine; David G Camp; Richard D Smith
Journal:  Mol Cell Proteomics       Date:  2006-07-19       Impact factor: 5.911

Review 3.  Proteomics: applications in transfusion medicine.

Authors:  Giancarlo Maria Liumbruno
Journal:  Blood Transfus       Date:  2008-04       Impact factor: 3.443

4.  Dynamically multiplexed ion mobility time-of-flight mass spectrometry.

Authors:  Mikhail E Belov; Brian H Clowers; David C Prior; William F Danielson; Andrei V Liyu; Brianne O Petritis; Richard D Smith
Journal:  Anal Chem       Date:  2008-06-18       Impact factor: 6.986

5.  Plasma profiles in active systemic juvenile idiopathic arthritis: Biomarkers and biological implications.

Authors:  Xuefeng B Ling; Jane L Park; Tanya Carroll; Khoa D Nguyen; Kenneth Lau; Claudia Macaubas; Edward Chen; Tzielan Lee; Christy Sandborg; Diana Milojevic; John T Kanegaye; Susanna Gao; Jane Burns; James Schilling; Elizabeth D Mellins
Journal:  Proteomics       Date:  2010-11-23       Impact factor: 3.984

Review 6.  Human body fluid proteome analysis.

Authors:  Shen Hu; Joseph A Loo; David T Wong
Journal:  Proteomics       Date:  2006-12       Impact factor: 3.984

7.  Improved profiling of low molecular weight serum proteome for gastric carcinoma by data-independent acquisition.

Authors:  Weifeng Li; Mengna Li; Xiaoli Zhang; Siqin Yue; Yun Xu; Wenjing Jian; Yin Qin; Lin Lin; Wenlan Liu
Journal:  Anal Bioanal Chem       Date:  2022-06-30       Impact factor: 4.478

8.  Glycoproteomics-based identification of cancer biomarkers.

Authors:  Evelyn H Kim; David E Misek
Journal:  Int J Proteomics       Date:  2011-09-28

9.  Biomarker development for non-invasive prenatal diagnosis of fetal aneuploidies: predictive reliability and potential clinical application.

Authors:  Aggeliki Kolialexi; Athanasios K Anagnostopoulos; Georgia Tounta; Aris Antsaklis; Ariadni Mavrou; George Th Tsangaris
Journal:  EPMA J       Date:  2011-05-18       Impact factor: 6.543

10.  Peptidome analysis of cerebrospinal fluid by LC-MALDI MS.

Authors:  Mikko Hölttä; Henrik Zetterberg; Ekaterina Mirgorodskaya; Niklas Mattsson; Kaj Blennow; Johan Gobom
Journal:  PLoS One       Date:  2012-08-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.